ArticleScientific reports2026
Morphological and nanomechanical insights into the selective targeting of breast cancer cells by novel nickel ferrite nanoparticles.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Antitumor efficacy of cobalt-zinc ferrite nanoparticles on MCF-7 cell line and Ehrlich ascites carcinoma bearing mice.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nickel Ferrite nanoparticles (NPs) have great potential for biomedical applications. These spinel ferrites exhibit unique physicochemical, magnetic and biocompatible properties that enable them to interact with biological cells. We report the use of immunofluorescence microscopy and Atomic Force Microscopy (AFM) in liquid to study their anticancer activity on live cells. Magnetic NPs were synthesized using novel solvothermal and hydrothermal routes, yielding sizes distributions centered at 8.6 ± 1.5 nm and 37.4 ± 1.5 nm, respectively. Their effect on the MCF-7 human breast cancer cells and the non-tumorigenic epithelial MCF-10 cell line was examined by monitoring morphological and nanomechanical responses using AFM. Complementary immunofluorescence microscopy observations and cell viability assays provided broader insights into their biological effects on a larger cell culture. Nickel ferrite NPs significantly altered nanomechanical properties and reduced viability of MCF-7 cancer cells. In contrast, they had minimal effect on healthy MCF-10 cells, as confirmed by AFM (cell height, RMS, and Young's modulus), immunofluorescence, and viability assays. Together, these results highlight a selective anticancer activity of these novel nickel ferrite NPs, supporting their potential as a sustainable and biocompatible alternative to conventional anticancer drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.